191 related articles for article (PubMed ID: 9680368)
41. Role of the CD40 and CD95 (APO-1/Fas) antigens in the apoptosis of human B-cell malignancies.
Wang D; Freeman GJ; Levine H; Ritz J; Robertson MJ
Br J Haematol; 1997 May; 97(2):409-17. PubMed ID: 9163608
[TBL] [Abstract][Full Text] [Related]
42. Fludarabine induces apoptosis of human T-cell leukemia virus type 1-infected T cells via inhibition of the nuclear factor-kappaB signal pathway.
Nishioka C; Ikezoe T; Yang J; Koeffler HP; Taguchi H
Leukemia; 2007 May; 21(5):1044-9. PubMed ID: 17344917
[TBL] [Abstract][Full Text] [Related]
43. In vitro modulation of bcl-2 protein expression, drug-induced apoptosis and cytotoxicity by interleukin-10 in chronic lymphocytic leukemia.
Morabito F; Filangeri M; Sculli G; Oliva B
Haematologica; 1998 Nov; 83(11):1046-8. PubMed ID: 9864930
[TBL] [Abstract][Full Text] [Related]
44. Inhibition of Oncogenic Transcription Factor REL by the Natural Product Derivative Calafianin Monomer 101 Induces Proliferation Arrest and Apoptosis in Human B-Lymphoma Cell Lines.
Yeo AT; Chennamadhavuni S; Whitty A; Porco JA; Gilmore TD
Molecules; 2015 Apr; 20(5):7474-94. PubMed ID: 25915462
[TBL] [Abstract][Full Text] [Related]
45. The role of NF-kappaB as a survival factor in environmental chemical-induced pre-B cell apoptosis.
Mann KK; Doerre S; Schlezinger JJ; Sherr DH; Quadri S
Mol Pharmacol; 2001 Feb; 59(2):302-9. PubMed ID: 11160867
[TBL] [Abstract][Full Text] [Related]
46. Differential roles of RelA (p65) and c-Rel subunits of nuclear factor kappa B in tumor necrosis factor-related apoptosis-inducing ligand signaling.
Chen X; Kandasamy K; Srivastava RK
Cancer Res; 2003 Mar; 63(5):1059-66. PubMed ID: 12615723
[TBL] [Abstract][Full Text] [Related]
47. Cytokine modulation of nuclear factor-kappaB activity in B-chronic lymphocytic leukemia.
Zaninoni A; Imperiali FG; Pasquini C; Zanella A; Barcellini W
Exp Hematol; 2003 Mar; 31(3):185-90. PubMed ID: 12644014
[TBL] [Abstract][Full Text] [Related]
48. BIRC3 Expression Predicts CLL Progression and Defines Treatment Sensitivity via Enhanced NF-κB Nuclear Translocation.
Asslaber D; Wacht N; Leisch M; Qi Y; Maeding N; Hufnagl C; Jansko B; Zaborsky N; Villunger A; Hartmann TN; Greil R; Egle A
Clin Cancer Res; 2019 Mar; 25(6):1901-1912. PubMed ID: 30487125
[TBL] [Abstract][Full Text] [Related]
49. Unique CD40-mediated biological program in B cell activation requires both type 1 and type 2 NF-kappaB activation pathways.
Zarnegar B; He JQ; Oganesyan G; Hoffmann A; Baltimore D; Cheng G
Proc Natl Acad Sci U S A; 2004 May; 101(21):8108-13. PubMed ID: 15148378
[TBL] [Abstract][Full Text] [Related]
50. Rapamycin inhibits doxorubicin-induced NF-kappaB/Rel nuclear activity and enhances the apoptosis of melanoma cells.
Romano MF; Avellino R; Petrella A; Bisogni R; Romano S; Venuta S
Eur J Cancer; 2004 Dec; 40(18):2829-36. PubMed ID: 15571967
[TBL] [Abstract][Full Text] [Related]
51. Targeting inhibitor of apoptosis proteins by Smac mimetic elicits cell death in poor prognostic subgroups of chronic lymphocytic leukemia.
Opel D; Schnaiter A; Dodier D; Jovanovic M; Gerhardinger A; Idler I; Mertens D; Bullinger L; Stilgenbauer S; Fulda S
Int J Cancer; 2015 Dec; 137(12):2959-70. PubMed ID: 26096065
[TBL] [Abstract][Full Text] [Related]
52. Constitutively Photomorphogenic 1 Reduces the Sensitivity of Chronic Lymphocytic Leukemia Cells to Fludarabine Through Promotion of Ubiquitin-Mediated P53 Degradation.
Fu C; Shi X; Gong Y; Wan Y; Sun Z; Shi H; Wang Z; Marinaccio C; Crispino JD; Xu K
Cell Physiol Biochem; 2018; 50(6):2314-2328. PubMed ID: 30423551
[TBL] [Abstract][Full Text] [Related]
53. Preclinical assessment of curcumin as a potential therapy for B-CLL.
Everett PC; Meyers JA; Makkinje A; Rabbi M; Lerner A
Am J Hematol; 2007 Jan; 82(1):23-30. PubMed ID: 16947318
[TBL] [Abstract][Full Text] [Related]
54. Dichotomy in NF-kappaB signaling and chemoresistance in immunoglobulin variable heavy-chain-mutated versus unmutated CLL cells upon CD40/TLR9 triggering.
Tromp JM; Tonino SH; Elias JA; Jaspers A; Luijks DM; Kater AP; van Lier RA; van Oers MH; Eldering E
Oncogene; 2010 Sep; 29(36):5071-82. PubMed ID: 20581863
[TBL] [Abstract][Full Text] [Related]
55. Dominant signals leading to inhibitor kappaB protein degradation mediate CD40 ligand rescue of WEHI 231 immature B cells from receptor-mediated apoptosis.
Schauer SL; Bellas RE; Sonenshein GE
J Immunol; 1998 May; 160(9):4398-405. PubMed ID: 9574544
[TBL] [Abstract][Full Text] [Related]
56. Synergistic and opposing regulation of the stress-responsive gene IEX-1 by p53, c-Myc, and multiple NF-kappaB/rel complexes.
Huang YH; Wu JY; Zhang Y; Wu MX
Oncogene; 2002 Oct; 21(44):6819-28. PubMed ID: 12360408
[TBL] [Abstract][Full Text] [Related]
57. TGF beta 1 inhibits NF-kappa B/Rel activity inducing apoptosis of B cells: transcriptional activation of I kappa B alpha.
Arsura M; Wu M; Sonenshein GE
Immunity; 1996 Jul; 5(1):31-40. PubMed ID: 8758892
[TBL] [Abstract][Full Text] [Related]
58. Upregulation of bfl-1 is a potential mechanism of chemoresistance in B-cell chronic lymphocytic leukaemia.
Olsson A; Norberg M; Okvist A; Derkow K; Choudhury A; Tobin G; Celsing F; Osterborg A; Rosenquist R; Jondal M; Osorio LM
Br J Cancer; 2007 Sep; 97(6):769-77. PubMed ID: 17726463
[TBL] [Abstract][Full Text] [Related]
59. [Function of alternative NF-κB activity in B-cell chronic lymphocytic leukemia cells].
Xu J; Zhou P; Guo F
Zhonghua Xue Ye Xue Za Zhi; 2014 Jan; 35(1):40-5. PubMed ID: 24602731
[TBL] [Abstract][Full Text] [Related]
60. Distinct nuclear factor-kappaB/Rel proteins have opposing modulatory effects in glutamate-induced cell death in HT22 cells.
Ishige K; Tanaka M; Arakawa M; Saito H; Ito Y
Neurochem Int; 2005 Dec; 47(8):545-55. PubMed ID: 16183169
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
